Brief: Heidelberg Pharma 9-month Net Loss At EUR 18.9 Mln

Heidelberg Pharma AG

07/10/2021 06:08

Oct 7 (Reuters) - HEIDELBERG PHARMA AG  HPHA.DE :
    * GUIDANCE REVISED
    * IN FIRST NINE MONTHS OF 2021 FISCAL YEAR, GROUP GENERATED
SALES
REVENUE AND INCOME TOTALING EUR 1.6 MILLION (PREVIOUS YEAR: EUR
8.3 MILLION)
    * AT EUR 0.5 MILLION, OTHER INCOME WAS ALSO DOWN ON
PRIOR-YEAR
FIGURE (EUR 0.8 MILLION) IN FIRST  NINE MONTHS
    * 9M FINANCIAL RESULT, WHICH MAINLY CONSISTS OF INTEREST
EXPENSES,
AMOUNTS TO EUR -0.3 MILLION (PREVIOUS YEAR: EUR -7 THOUSAND)
    * 9M NET LOSS FOR FIRST NINE MONTHS OF FISCAL YEAR ROSE TO
EUR
18.9 MILLION (PREVIOUS YEAR: EUR 12.5 MILLION)
    * COMPANY'S FINANCING IS STILL SECURED UNTIL MID-2022.
    * EXPECTS OR FINANCIAL YEAR 2021 SALES AND OTHER INCOME
BETWEEN
EUR 2.0 MILLION AND EUR 2.5 MILLION (PREVIOUSLY: EUR 5.5 MILLION
TO EUR 7.5 MILLION)
    * AN OPERATING RESULT (EBIT) BETWEEN EUR -23.5 MILLION AND
EUR
-26.5 MILLION IS EXPECTED (PREVIOUSLY: EUR -30.0 MILLION TO EUR
-34.0 MILLION) EXPECTED FOR 2021

Source text for Eikon:  ID:nEQ6gPC8ma 
Further company coverage:  HPHA.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))